| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5691163 | Urology | 2017 | 27 Pages |
Abstract
Comprehensive prescreening discussions about advantages and disadvantages of PSA testing are critical to informed decision making about prostate cancer screening. Disparities not only exist with regard to the quality of prescreening discussions that patients receive from their providers prior to PSA testing across categories of race/ethnicity, education, income, and insurance status, but these disparities became more substantial between 2012 and 2014. Further investigation is warranted to elicit more specific reasons behind these variations.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
George A. III, Annie Gjelsvik, Joseph F. II,